Bull & Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the live evidence is on the bull side, but the entry leaves no margin if RoTCE compresses materially. Bull holds the harder-to-fake signals: Q1 2026 NIM rose 16 bps to 3.45% as the ECB cut from 4% toward 2% (deposit beta of 35%), the CEO put €1.19m of personal cash in at €147.50 on 29 April, eight days after that print, and three consecutive years of 25%+ RoTCE survived three rate regimes. Bear holds the math: 3.0× P/TB requires the 27% RoTCE to be near-permanent; AIB at 22% RoTCE prints 1.5× P/TB, and management's own through-cycle floor is "above 20%", not 27%. The decisive tension is whether the FY25 RoTCE is the new structural baseline or the cyclical peak — Q2/Q3 2026 prints on a clean post-Knab/Barclays base settle it. Until then, the asymmetry above the bear's €85 downside and below the bull's €185 target is too narrow to underwrite a full-conviction long.

Bull Case

Price target: €185 on 3.5× P/TB applied to FY26E TBVPS of ~€53 (FY25 €43.17 compounding ~12% with reinvestment at 27% RoTCE × 45% retained), validated against 15× FY27E EPS of ~€12.50 anchored on management's reconfirmed >€960m FY26 and >€1.1bn FY27 net-profit guidance. Timeline 12–18 months. Primary catalyst: Q2 2026 RoTCE print (Jul 2026) — first clean post-Knab/Barclays integration quarter; ≥25% closes the "27% is peak" debate. Disconfirming signal: cumulative deposit beta drifting above 50% or customer-funding-to-loans below 110%.

Bear Case

Downside target: €85 on 1.8× P/TB applied to a modestly-grown TBVPS of ~€47 over 12–18 months, anchored to a normalised 22% RoTCE; AIB-comparable 1.5× P/TB triangulates to ~€71. Timeline 12–18 months, aligned to Q3 2026 results (first clean post-Knab/Barclays comparable), PTSB closing in Q4 2026 / Q1 2027, and ECB settling near 2%. Primary trigger: Q3 2026 RoTCE below 25% on clean base, OR PTSB Day-1 pro-forma CIR above 45%, OR FY26 risk costs above 45 bps without a fresh mix story. Cover signal: clean Q3/Q4 2026 RoTCE ≥25% AND NIM above 3.20% AND PTSB Day-1 CIR below 42% within 6 months of close.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight today because the evidence is live rather than projected: Q1 2026 already showed NIM rising as the ECB cut, the CEO committed €1.19m of personal cash at €147.50 a week before that print, and three consecutive years of 25%+ RoTCE survived every regime the file has tested. The decisive tension remains whether 27% RoTCE is the new baseline or the cyclical peak — and bear is right that management itself underwrites only "above 20%", that the multiple at 3.0× P/TB leaves no margin if RoTCE compresses, and that PTSB attacks a defended duopoly unlike the prior 14 deals. The bear path requires both (1) RoTCE to step down materially from 27% toward 22%, and (2) the multiple to compress toward AIB's 1.5× P/TB — neither has begun in the data, but neither has been ruled out. The verdict changes to a clean Lean Long if Q2/Q3 2026 RoTCE prints at or above 25% on a post-acquisition clean base AND PTSB Day-1 pro-forma CIR comes in below 42%. It changes to Avoid if Q3 2026 RoTCE drops below 25% on a clean base, or PTSB Day-1 CIR prints above 45%.